Navigating Cardiotoxicity in Modern Cancer Therapy - Ep 181

About this episode

The episode discusses the expanding concerns of cardiotoxicity in cancer therapy with a focus on types, monitoring, and management.

In this episode, Pharmacotherapy scientific editor Jim Koeller interviews hematology-oncology specialist Dennis Marjoncu about Dr. Marjoncu's narrative review article “ Cancer Therapy-Induced Cardiotoxicity ”. They discuss how cardiotoxicity concerns have expanded beyond anthracyclines. They review cardiotoxicity types, monitoring approaches, management principles, drug-interaction considerations, limited prevention data, guideline gaps, and the need for better risk stratification and trial-based cardiac data.

People in this episode

Guest: Dennis Marjoncu

Topics covered

• cardiotoxicity
• cancer therapy
• hematology-oncology
• drug interactions
• risk stratification

Keywords

• Pharmacotherapy
• narrative review
• guideline gaps
• trial-based cardiac data

Mentioned in this episode

Books & works: Navigating Cardiotoxicity in Modern Cancer Therapy, “ Cancer Therapy-Induced Cardiotoxicity ”

More episodes of ACCP JOURNALS

• Getting Published in JACCP: Tips for Success - Ep 184 · June 9, 2026 · 28 min
• Predicting Fall Risks in Older Adults with Depression: A Machine Learning Approach - Ep 183 · May 19, 2026 · 30 min
• Reimagining Renal Assessment: Pros and Cons - Ep 182 · May 12, 2026 · 38 min
• High-Value Interventions Primary Care Practices Might Be Overlooking: Clinical Pharmacy Services – Ep 180 · April 7, 2026 · 36 min
• Enhancing Pharmacotherapy Through Artificial Intelligence: From Prediction Models to Practice – Ep 179 · March 25, 2026 · 24 min
• A Medical Writing Rotation: Flipping the Odds on Resident Scholarship - Ep 178 · March 16, 2026 · 24 min